Startups
Care Access operates as one connected team of physicians and research experts with its Mobile Sites On Demand capability (“Pop-Up Sites”) to break down traditional barriers and accelerate the delivery of critical, life-saving therapies. Care Access pioneered this unique mobile decentralized trial delivery model in partnership with leading research sponsors to deliver their most critical trials. Additionally, Care Access conducts several hundred clinical trials at its 60 research sites nationwide and brings more physicians into clinical research through its innovative Sites On Demand service. To learn more about how Care Access helps clinical trial delivery, visit https://www.careaccess.com/.
Overview
Location
United States, Massachusetts, Boston
Employees
201-500
Phone
+1 617-963-5155
Founded date
2001
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 23, 2026 | Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss | Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the results, but cited “strong efficacy” for its ... |
| Jun 29, 2022 | Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America | What You Should Know: – Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin Amer... |
| HIMSS21 Day 3 Roundup: Sharecare Acquires CareLinx, Verizon Telehealth, Samsung | Sharecare Acquires On-Demand Home Health Platform CareLinx for $65M Sharecare today announced that it has closed its acquisition of CareLinx , an on-demand home health platform of tech-enabled care providers from Europ Assistance, one of th... | |
| DexCare: Patient Demand And Care Access Platform Company Closes $75 Million In Series C | DexCare – a leading patient demand and care access platform – recently announced the closing of its $75 million Series C funding round led by ICONIQ Growth. This funding round will advance DexCare’s platform, which extends limited health-sy... | |
| Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials | What You Should Know: – Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICO... |
Reviews 0
FAQ about Care Access
When was Care Access founded?
Care Access was founded in 2001.
What has the press written about Care Access?
Parsers VC has collected 6 articles mentioning Care Access, among them “Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss” (Mar 23, 2026) and “Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America” (Jun 29, 2022).
Is Care Access still active?
Yes, Care Access is active; its latest activity on Parsers VC dates from Aug 11, 2026.